- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT00500474
Effects of Endolymphatic Sac Drainage With Steroids for Meniere's Disease (EDSS)
Clinical Study of Endolymphatic Sac Drainage With or Without Steroids for Intractable Meniere's Disease
Study Overview
Status
Conditions
Intervention / Treatment
Detailed Description
Meniere's disease characterized by recurrent attacks of vertigo, fluctuating hearing loss and tinnitus, is a common disease with an incidence of 15-50 per 100,000 population. Some patients with Meniere's disease are strongly prevented from participating in activities of daily life and interaction with their social environment, such as work and schooling, due to frequent attacks of vertigo especially with progressive sensorineural hearing loss, in spite of various kinds of medication. This type of Meniere's disease is called intractable Meniere's disease. Although the oto-pathology in Meniere's temporal bones was revealed in 1938 to be inner ear endolymphatic hydrops, the definitive pathogenesis of Meniere's disease is still unknown and there is no radical treatment for this disease.
It has, however, been reported that Meniere's disease is usually triggered by immune, metabolic, infectious, traumatic or other insults to the inner ear, associated with a small misplaced malfunctioning endolymphatic sac. Among these insults, immune-mediated responses in the inner ear endo-organs such as the endolymphatic sac, stria vascularis and spiral ligament, are thought to be the main reason for the development of symptoms in Meniere's disease. Thus, systemic administration and/or local perfusion of corticosteroids into the middle ear have been adopted as an anti-immune or anti-inflammatory therapy for patients with intractable Meniere's disease. These treatments were reported to result in good relief from vertigo and improvement of hearing in some cases. However, these results especially for hearing did not last long enough to discontinue additional repetitive applications of steroids. Since Meniere's disease is characterized by repeated attacks of vertigo with fluctuating and/or progressive hearing loss unlike other inner ear diseases without recurrence such as sudden deafness and vestibular neuritis, it is necessary to refrain from repetitive applications of steroids for the long-term follow-up with Meniere's patients because of side effects.
For inner ear drug delivery, we noted another hopeful but unevaluated route, the longitudinal route from the endolymphatic sac to the cochlea and vestibule, suggested by several lines of evidence in animal studies. Morgenstern et al. and Lee et al. demonstrated that the intra-endolymphatic sac materials could reach the cochlear endolymphatic site through the vestibular aqueduct using a test marker and an oto-toxic drug, respectively. Recently, Yamasoba et al. suggested the possibility of gene therapy through the vestibular aqueduct route. We also revealed that intra-endolymphatic sac steroids could up-regulate a water channel molecule, aquaporin-3 mRNA in the cochlea.
In the present study, we examined the intra-endolymphatic sac application of large doses of steroids as de novo treatment for intractable Meniere's disease.
Study Type
Enrollment (Actual)
Phase
- Not Applicable
Contacts and Locations
Study Locations
-
-
Osaka
-
Suita-city, Osaka, Japan, 565-0871
- Department of Otolaryngology, Osaka University, School of Medicine
-
-
Participation Criteria
Eligibility Criteria
Ages Eligible for Study
- Child
- Adult
- Older Adult
Accepts Healthy Volunteers
Genders Eligible for Study
Description
Inclusion Criteria:
- Clinical diagnosis of Meniere's Disease, who did not respond to various forms of medical and psychological managements for at least 6 months, i.e. intractable Meniere's disease.
Exclusion Criteria:
- Other known causes of vertigo including central lesion
Study Plan
How is the study designed?
Design Details
- Primary Purpose: Treatment
- Allocation: Randomized
- Interventional Model: Parallel Assignment
- Masking: Single
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Time Frame |
---|---|
the ratio of patients in vertigo supression and hearing improvement
Time Frame: post-operative 2-7 years
|
post-operative 2-7 years
|
Secondary Outcome Measures
Outcome Measure |
Time Frame |
---|---|
the ratio of patients in canal improvement
Time Frame: post-operative 2 years
|
post-operative 2 years
|
Collaborators and Investigators
Sponsor
Investigators
- Principal Investigator: Tadashi Kitahara, M.D.,Ph.D., Department of Otolaryngology, Osaka University, School of Medicine
Publications and helpful links
General Publications
- Kitahara T, Fukushima M, Uno Y, Mishiro Y, Kubo T. Up-regulation of cochlear aquaporin-3 mRNA expression after intra-endolymphatic sac application of dexamethasone. Neurol Res. 2003 Dec;25(8):865-70. doi: 10.1179/016164103771953989.
- Kitahara T, Horii A, Imai T, Ohta Y, Morihana T, Inohara H, Sakagami M. Effects of endolymphatic sac decompression surgery on vertigo and hearing in patients with bilateral Meniere's disease. Otol Neurotol. 2014 Dec;35(10):1852-7. doi: 10.1097/MAO.0000000000000469.
Study record dates
Study Major Dates
Study Start
Study Completion (Actual)
Study Registration Dates
First Submitted
First Submitted That Met QC Criteria
First Posted (Estimate)
Study Record Updates
Last Update Posted (Estimate)
Last Update Submitted That Met QC Criteria
Last Verified
More Information
Terms related to this study
Keywords
Additional Relevant MeSH Terms
Other Study ID Numbers
- tk19661217
- tk20090401
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.
Clinical Trials on Meniere's Disease
-
University Hospital, GrenobleNot yet recruitingInner Ear ; Meniere's Disease; Imaging
-
Norfolk and Norwich University Hospitals NHS Foundation...University of East Anglia; Ménière's SocietyCompleted
-
Medical University of South CarolinaAmerican Hearing Research Foundation; Cures within Reach FoundationCompletedMeniere DiseaseUnited States
-
Otonomy, Inc.Terminated
-
Beijing Tongren HospitalCompleted
-
Otonomy, Inc.Terminated
-
Alvogen KoreaCompleted
-
Ludwig-Maximilians - University of MunichCompletedMénière's DiseaseGermany
-
University Hospital, BordeauxCompleted
-
University of California, San DiegoAmerican Society of Head and Neck RadiologyCompletedMeniere's DiseaseUnited States
Clinical Trials on endolymphatic sac drainage with steroids
-
TripleMed B.V.Trium Clinical ConsultingSuspended
-
Riphah International UniversityRecruitingChronic Obstructive Pulmonary DiseasePakistan
-
Third Military Medical UniversityCompletedRectal Neoplasms | Anastomotic LeakageChina
-
Boston Medical CenterCompletedCutaneous AbscessUnited States
-
University Hospital, Clermont-FerrandCompletedPneumothorax | Hemothorax | Pleural EffusionFrance
-
Santi MangiaficoNot yet recruiting
-
Beni-Suef UniversityCompleted
-
Radboud University Medical CenterTerminatedPneumoniaNetherlands
-
University Hospital, ToursCompleted
-
Palacky UniversityCompletedPancreatitis, Acute Necrotizing | Walled Off NecrosisCzechia